CXCL12 and breast cancer: Recent single-cell transcriptomics and functional co-culture experiments reported that CD26+ normal fibroblasts transition into pro-tumorigenic inflammatory CAFs which recruit myeloid cells through a CXCL12-dependent manner and induce tumor cell invasion via matrix-metalloproteinase activity in breast cancer (23).